BioCentury
ARTICLE | Company News

IBL, Tecan deal

August 11, 2014 7:00 AM UTC

Tecan will acquire IBL for EUR29 million ($38.9 million) in cash. Tecan said IBL, which markets microtiter plate-based immunoassays, will become a part of Tecan’s Life Sciences business. IBL recorded ...